CV Sciences Inc (CVSI)

[captainjonesthe3rd]

How the FDA may regulate CBD market(see REQUIRE... below):
FDA continues to take steps to improve its oversight of food safety. To address critical issues related to the overall safety of the food we eat, FDA intends to propose a rule on lab accreditation, which would establish a program to accredit labs to do food safety testing and to REQUIRE that these accredited labs be used in certain situations.

Additionally, in the Unified Agenda, FDA committed to pursuing a rulemaking that will clarify registration requirements for food facilities to better align how facilities and farms that perform similar activities are treated under the preventive controls rules and the produce safety rule.

https://blogs.fda.gov/fdavoice/index.php/2017/12/looking-ahead-some-of-fdas-major-policy-goals-for-2018/

Also another potential direction:
Broadening Access to Nonprescription Drugs: We are considering innovative action in the nonprescription drug area to expand the scope of drug products that can be made available to consumers without a prescription. We will be proposing to allow certain innovative approaches for demonstrating that a drug product can be used safely and effectively in a nonprescription setting. This will allow some drugs that would otherwise require a prescription to be marketed without a prescription through the use of innovative technologies and other conditions that will ensure appropriate self-selection and/or appropriate actual use of the nonprescription drug product by consumers. Examples of such conditions could include use of self-selection questions on a mobile medical app prior to permitting access to the drug, or other innovative technologies to improve safety. Through use of these types of additional conditions, we hope to create a new paradigm of drug safety with greater flexibility that will benefit patients and public health. We are committed to advancing this new framework to enable a potentially broader selection of nonprescription products for consumers, empowering them to self-treat more common conditions and chronic conditions. This also could help lower costs by increasing the availability of products that would otherwise be available only by prescription.

https://blogs.fda.gov/fdavoice/index.php/2017/12/looking-ahead-some-of-fdas-major-policy-goals-for-2018/

and this is a snippet from the Wisconsin bill that just passed and rumours Indiana could have something similar in their new bill:
(9) TESTING OF INDUSTRIAL HEMP INTENDED FOR CONSUMPTION. (a) All industrial hemp and each industrial hemp product intended for human consumption shall be tested, in its final consumer-ready state, by an independent testing laboratory to confirm that it is nonpsychoactive and contains safe levels of potential contaminants.
An independent testing laboratory shall have all of the following:
1. Accreditation by an impartial organization that provides accreditation pursuant to the standard ISO/IEC 17025 of the International Organization for Standardization and that is a signatory to the International Laboratory Accreditation Corporation Mutual Recognition Arrangement, or other comparable accreditation standard required by the department....